TY - JOUR
T1 - A comprehensive meta-regression analysis on outcome of anatomic resection versus nonanatomic resection for hepatocellular carcinoma
AU - Cucchetti, Alessandro
AU - Cescon, Matteo
AU - Ercolani, Giorgio
AU - Bigonzi, Eleonora
AU - Torzilli, Guido
AU - Pinna, Antonio D.
PY - 2012/11
Y1 - 2012/11
N2 - Background. It remains unclear whether hepatectomy for hepatocellular carcinoma should be performed as an anatomic resection (AR) or a nonanatomic resection (NAR). Because no randomized controlled trials are currently available on this topic, a meta-regression analysis was performed on available observational studies to control for confounding variables. Methods. A systematic review of studies published from 1990 to 2011 in the PubMed and Embase databases was performed. Patient and disease-free survival (DFS), postoperative mortality, and morbidity were considered Abstract: outcomes. Results are expressed as relative risk (RR) or weighted mean differences with 95 % of confidence interval. Results. Eighteen observational studies involving 9,036 patients were analyzed: 4,012 were in the AR group and 5,024 in the NAR group. Meta-analysis suggested that AR provided better 5-year patient survival (RR 1.14; P = 0.001) and DFS than NAR (RR 1.38; P = 0.001). However, patients in the NAR group were characterized by a higher prevalence of cirrhosis (RR 1.27; P = 0.010), more advanced hepatic dysfunction (RR 0.90 for Child- Pugh class A; P = 0.001) and smaller tumor size (weighted mean difference 0.36 cm; P
AB - Background. It remains unclear whether hepatectomy for hepatocellular carcinoma should be performed as an anatomic resection (AR) or a nonanatomic resection (NAR). Because no randomized controlled trials are currently available on this topic, a meta-regression analysis was performed on available observational studies to control for confounding variables. Methods. A systematic review of studies published from 1990 to 2011 in the PubMed and Embase databases was performed. Patient and disease-free survival (DFS), postoperative mortality, and morbidity were considered Abstract: outcomes. Results are expressed as relative risk (RR) or weighted mean differences with 95 % of confidence interval. Results. Eighteen observational studies involving 9,036 patients were analyzed: 4,012 were in the AR group and 5,024 in the NAR group. Meta-analysis suggested that AR provided better 5-year patient survival (RR 1.14; P = 0.001) and DFS than NAR (RR 1.38; P = 0.001). However, patients in the NAR group were characterized by a higher prevalence of cirrhosis (RR 1.27; P = 0.010), more advanced hepatic dysfunction (RR 0.90 for Child- Pugh class A; P = 0.001) and smaller tumor size (weighted mean difference 0.36 cm; P
UR - http://www.scopus.com/inward/record.url?scp=84868136479&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84868136479&partnerID=8YFLogxK
U2 - 10.1245/s10434-012-2450-z
DO - 10.1245/s10434-012-2450-z
M3 - Article
C2 - 22722807
AN - SCOPUS:84868136479
SN - 1068-9265
VL - 19
SP - 3697
EP - 3705
JO - Annals of Surgical Oncology
JF - Annals of Surgical Oncology
IS - 12
ER -